BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19169058)

  • 1. The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.
    Vilar L; Freitas MC; Naves LA; Canadas V; Albuquerque JL; Botelho CA; Egito CS; Arruda MJ; Silva LM; Arahata CM; Agra R; Lima LH; Azevedo M; Casulari LA
    J Endocrinol Invest; 2008 Nov; 31(11):1008-13. PubMed ID: 19169058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endogenous Cushing's syndrome: clinical and laboratorial features in 73 cases].
    Vilar L; Naves LA; Freitas Mda C; Moura E; Canadas V; Leal E; Teixeira L; Gusmão A; Santos V; Campos R; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Lyra R; Azevedo MF; Casulari LA
    Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):566-74. PubMed ID: 17684617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test.
    Chen K; Chen S; Lu L; Zhu H; Zhang X; Tong A; Pan H; Wang R; Lu Z
    Front Endocrinol (Lausanne); 2021; 12():720823. PubMed ID: 34539574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Barbot M; Trementino L; Zilio M; Ceccato F; Albiger N; Daniele A; Frigo AC; Mardari R; Rolma G; Boscaro M; Arnaldi G; Scaroni C
    Pituitary; 2016 Oct; 19(5):488-95. PubMed ID: 27236452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovine CRH Stimulation and 8 mg Dexamethasone Suppression Tests in 323 Patients With ACTH-Dependent Cushing's Syndrome.
    Elenius H; McGlotten R; Nieman LK
    J Clin Endocrinol Metab; 2023 Dec; 109(1):e182-e189. PubMed ID: 37531629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.
    Tsagarakis S; Tsigos C; Vasiliou V; Tsiotra P; Kaskarelis J; Sotiropoulou C; Raptis SA; Thalassinos N
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
    Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
    Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
    Dias R; Storr HL; Perry LA; Isidori AM; Grossman AB; Savage MO
    Horm Res; 2006; 65(3):159-62. PubMed ID: 16514243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive Diagnostic Strategy in ACTH-dependent Cushing's Syndrome.
    Frete C; Corcuff JB; Kuhn E; Salenave S; Gaye D; Young J; Chanson P; Tabarin A
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32594169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Diagnostic Utility of Overnight High-Dose Dexamethasone Suppression Test in ACTH-Dependent Cushing's Syndrome.
    Kumar A; Kanwar J; Bharti N; Agrawal V; Bhatia E; Yadav SC
    Endocr Pract; 2021 Jul; 27(7):723-727. PubMed ID: 34250909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndrome.
    Qiao J; Li J; Zhang W; Wang C; Li J; Jiang S; Tan H; Chen Y; Liu H; Cai B; Yu Y
    Endocr J; 2021 Jul; 68(7):839-848. PubMed ID: 33790062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Testing for Differential Diagnosis of ACTH-Dependent Cushing Syndrome: A Systematic Review and Meta-analysis.
    Ceccato F; Barbot M; Mondin A; Boscaro M; Fleseriu M; Scaroni C
    J Clin Endocrinol Metab; 2023 Apr; 108(5):e178-e188. PubMed ID: 36453141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.
    Tsagarakis S; Vassiliadi D; Kaskarelis IS; Komninos J; Souvatzoglou E; Thalassinos N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2080-6. PubMed ID: 17356045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bilateral inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
    Belli S; Oneto A; Mendaro E
    Rev Med Chil; 2007 Sep; 135(9):1095-102. PubMed ID: 18064362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndrome.
    Detomas M; Ritzel K; Nasi-Kordhishti I; Wolfsberger S; Quinkler M; Losa M; Tröger V; Kroiss M; Fassnacht M; Vila G; Honegger JB; Reincke M; Deutschbein T
    Front Endocrinol (Lausanne); 2022; 13():955945. PubMed ID: 36277711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.